Deregulated APE1/Ref-1 is associated with various human pathologies, such as cancer, atherosclerosis, neurodegeneration, and infectious diseases, making it a potential therapeutic target (Thakur et al., 2014; Shah et al., 2017). Here, APEX1 is linked to atherosclerosis.